Next Article in Journal
Potential Target Receptors for the Pharmacotherapy of Burning Mouth Syndrome
Next Article in Special Issue
Evaluation of the Potential Benefits of Trimetazidine in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomized Controlled Trial
Previous Article in Journal
Effect of CYP1A2, CYP2D6, and CYP3A4 Variation on Antipsychotic Treatment Outcomes
Previous Article in Special Issue
Efficacy and Safety of Novel Oral Anti-Cholestatic Agents for Primary Biliary Cholangitis: Meta-Analyses and Systematic Review
 
 
Review

Article Versions Notes

Pharmaceuticals 2025, 18(6), 893; https://doi.org/10.3390/ph18060893
Action Date Notes Link
article pdf uploaded. 14 June 2025 11:45 CEST Version of Record https://www.mdpi.com/1424-8247/18/6/893/pdf-vor
article xml file uploaded 16 June 2025 09:53 CEST Original file -
article xml uploaded. 16 June 2025 09:53 CEST Update https://www.mdpi.com/1424-8247/18/6/893/xml
article pdf uploaded. 16 June 2025 09:53 CEST Updated version of record https://www.mdpi.com/1424-8247/18/6/893/pdf
article html file updated 16 June 2025 09:55 CEST Original file -
article html file updated 25 June 2025 09:40 CEST Update https://www.mdpi.com/1424-8247/18/6/893/html
Back to TopTop